Immunotherapy Insights

Associate Editor:

Barbara A Guinn, PhD
Principal Investigator, Department of Haematological Medicine, King's College London School of Medicine, London, UK

Dr. Guinn is a Senior Research Fellow at The University of Southampton and a visiting scientist at King’s College London. Dr. Guinn gained her B.Sc. in Genetics from the University of Wales, Aberystwyth in 1991 and a Ph.D. in Medicine from the University of Wales College of Medicine, Cardiff in 1995. Dr. Guinn was one of the first Leukaemia Research Fund Gordon Piller Ph.D. students in the year this prestigious award was initiated. Dr. Guinn undertook two postdoctoral fellowships at the University of Toronto (Autologous Bone Marrow Transplant Unit, Toronto General Hospital and Department of Immunology) and has maintained a history of support from the Leukaemia Research Fund throughout her career. In addition, Dr Guinn has received funding from Cancer Research U.K., the Elimination of Leukaemia Fund, Wessex Cancer Trust and British Society for Haematology. Dr. Guinn has published over 50 peer-reviewed manuscripts. She is on the editorial board of five journals and reviews manuscripts for more than 30 scientific journals on an ad hoc basis.

Dr. Guinn’s research at King’s College London, and more recently at the University of Southampton, has focused on the identification of leukaemia antigens in acute myeloid leukaemia using SEREX, microarray and RT-PCR. A number of epitopes from these antigens have been inserted into DNA vaccines and tested for suitability for near-future clinical trials. Dr. Guinn’s group has also worked on whole cell vaccines for acute myeloid leukaemia and B-cell lymphoma, and the development of tetramer arrays as a clinical end-point assay.  

Editorial Board:

The Editor in Chief welcomes applications to join the journal's volunteer peer reviewer pool and editorial board

Persis Amrolia, PhD
Professor of Transplantation Immunology, Molecular Immunology Unit, UCL Institute of Child Health, London; Honorary Consultant in Bone Marrow Transplant, Department of Bone Marrow Transplant, Great Ormond St Children's Hospital, London, England

Dario Campana, PhD, MD
Professor, Department of Paediatrics,  Yong Loo Lin School of Medicine, National University of Singapore, Singapore

Daniel Douek, MD
Senior Investigator, Vaccine Research Centre, National Institutes of Health, Bethesda, Maryland, USA

JH Frederik Falkenburg, PhD
Professor of Hematology, Hematology, Leiden University Medical Centre, Leiden, Netherlands

Stephen Gottschalk, MD
Associate Professor, Center for Cell and Gene Therapy, Texas Children's Cancer Center, Texas Children's Hospital, The Methodist Hospital, Baylor College of Medicine, Houston, Texas, USA

Peiman Hematti, MD
Associate Professor of Medicine, Medicine, Hematology, Oncology, Bone Marrow Transplant, University of Wisconsin-Madison, Madison, Wisconsin, USA

Arvind Madaan, MD, FAAAAI
President, Charlottesville Allergy & Respiratory Enterprises (CARE), Charlottesville, Virginia, USA

Jan Joseph Melenhorst, PhD
Staff Scientist, Hematology, National Institutes of Health, National Heart, Lung and Blood Institute, Bethesda, Maryland, USA

Jaroslav Michalek, PhD
Professor of Pediatrics, Head, Advanced Cell Immunotherapy Unit, Department of Pharmacology, Masaryk University, Brno, Czech Republic

Katayoun Rezvani, PhD, MD
Professor of Medicine, Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Centre, Houston, Texas, USA

Anthony P Schwarer, PhD
Department of Haematology & Department of Immunology, Monash University; Department of Haematology, Box Hill Hospital (Melbourne) and Alfred Hospital (Melbourne), Australia

Shimon Slavin, MD
Professor of Medicine, Scientific & Medical Director, The International Center for Cell Therapy & Cancer Immunotherapy (CTCI), Weizman Center, Tel Aviv, Israel

Adrian Thrasher, PhD
Professor of Paediatric Immunology and Honorary Consultant Paediatric Immunologist, Director of the Centre for Immunodeficiency, Molecular Immunology Unit, UCL Institute of Child Health, London, England

Frits van Rhee, PhD, MD, MRCP, FRCPath
Professor of Medicine, Director of Developmental and Translational Medicine, Charles & Clydene Scharlau Chair for Hematological Malignancies Research, Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA

Robert Yarchoan, MD
Chief, HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA